Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Stroke

Fluoxetine does not assist recovery following stroke, research suggests

Study suggests that the serotonergic antidepressant, fluoxetine, should not be used routinely in stroke recovery after study finds no difference from placebo on functional status.

CT scan of stroke patient

Source: Shutterstock.com

The results of the study did not support the routine use of fluoxetine for the prevention of post-stroke depression or to promote recovery of function

Daily fluoxetine in patients who have had a stroke does not improve functional outcomes at six months, results of a randomised trial published in The Lancet (5 December 2018) have shown[1].

The study included 3,127 patients with focal neurological deficits who all enrolled within 2–15 days of stroke onset. They were randomly assigned to either daily fluoxetine 20mg or placebo for six months.

At the end of the study, functional status, as measured on the modified Rankin scale, was similar between the groups, indicating that fluoxetine 20mg did not influence patients’ functional outcomes. 

Patients in the fluoxetine group were significantly less likely to develop depression than those in the placebo group (13.4% vs. 17.2% respectively; 95% confidence interval [CI] 1.26–6.30; P=0.0033), but were more likely to experience bone fractures (2.9% for fluoxetine vs. 1.5% in the placebo group; 95% CI 0.38–2.43; P=0.0070).

Fluoxetine is used to treat depression and emotional lability after stroke and it has been suggested that its neurological effects could also enhance recovery of function, the authors explained.

“These results do not support the routine use of fluoxetine either for the prevention of post-stroke depression or to promote recovery of function,” they wrote.

Future trials are needed to explore if any particular subgroups might benefit from post-stroke fluoxetine and to clarify potential harms of the drug in stroke patients, they concluded.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2019.20205990

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmacy Registration Assessment Questions 2

    Pharmacy Registration Assessment Questions 2

    Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.

    £35.00Buy now
  • Pharmacy Registration Assessment Questions 3

    Pharmacy Registration Assessment Questions 3

    Pharmacy Registration Assessment Questions 3 is the third volume in a series that follows on from the previous, highly popular Pharmacy Registration Assessment Questions 2. It features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own.

    £35.00Buy now
  • Pharmacy Registration Assessment Questions Package

    Pharmacy Registration Assessment Questions Package

    Pharmacy Registration Assessment Questions is a revision series featuring closed book and calculation questions. It can be used in conjunction with previous volumes or on its own to help you prepare for the GPHC exams.

    £80.00Buy now
  • Palliative Care Formulary (PCF6)

    Palliative Care Formulary (PCF6)

    Palliative Care Formulary is a comprehensive combination of independent information about drugs used in palliative care.

    £55.00Buy now
  • Martindale: The Complete Drug Reference

    Martindale: The Complete Drug Reference

    Martindale: The Complete Drug Reference provides reliable, unbiased and evaluated information on drugs and medicines used throughout the world.

    £570.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.